Welcome and Introduction to the IPC and SOLAPSO
Ricardo Romiti, MD, PhD, Brazil & Fernando Valenzuela, MD, Chile
Advances in the Management of Scalp Psoriasis
Claudia de la Cruz, MD, Chile
How I Treat the Scalp
César Gonzalez, MD, Colombia
Advances in the Management of Nail Psoriasis
Enrique Rivas, MD, Guatemala
How I Treat the Nails
Fernando Valenzuela, MD, Chile
Advances in the Management of Palmoplantar Psoriasis
Anber Tanaka, MD, Brazil
How I Treat the Palms and Soles
Marcelo Arnone, MD, Brazil
Panel Discussion
Ricardo Romiti, MD, PhD, Brazil – facilitator
Methotrexate: What Have We Learned in 75 Years
Angela Londoño, MSc, MD, Colombia
CLCI in Patients with Psoriasis
Ricardo Romiti, MD, PhD, Brazil
GPP: Still a Neglected Disease?
Juan Raul Castro Ayarza, MD, Colombia
What´s the Role of Small Molecules in the Treatment of Psoriasis?
Gabriel Magariños, MD, Argentina
New Biologics
André Esteves de Carvalho, MD, PhD, Brazil
Panel Discussion
Enrique Rivas, MD, Guatemala – facilitator
IPC Councilor Helen Young provides commentary on a study identifying skin-derived myeloid precursors and CD200+ fibroblasts as key drivers of psoriatic disease spread from the skin to joints, highlighting the CD200–CD200R1 axis as a promising therapeutic target.
IPC Fellow Dr. Yemsrach Abawaji shares her firsthand perspective on the barriers to psoriasis diagnosis and treatment in Ethiopia and opportunities to improve care.
Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.
Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.
